Scan to Download ios&Android APP

Smiths Group agrees on ICU sale worth $2.4bn

08:17, 8 September 2021

Share this article

Have a confidential tip for our reporters?

Smiths Group logo on smartphone screen
Smiths Group plc logo on smartphone - Photo: Shutterstock

British engineering company Smiths Group has agreed the sale of its Smiths Medical division to US-based ICU Medical, it was announced on Wednesday.

The transaction is said to be worth $2.4bn and will bring more value to shareholders. As a result of this, the Smiths board has withdrawn its recommendation to enter a sale with TA Associates.

Smiths Group's stock price was up almost 5% in morning trading on Wednesday at £14.81 (US$20.38). 

Sale agreed

Smiths Group plc announces that it has agreed the sale of Smiths Medical to ICU Medical, Inc on terms that are superior to the previously announced transaction entered into with TA Associates on 2 August 2021,” the statement said.

In July, the Mail on Sunday reported that £2bn was being offered by TA Associates for the medical arm, which is based in Minneapolis.

Smiths said that the sale of its medical division will “simplify and position Smiths for focused growth” in its industrial technology business.

Shareholder value

Smiths, whose medical business manufactures equipment such as catheters and pain management devices, is also one of the UK’s last industrial conglomerates. The company has been considering a demerger since 2019. The previous chief executive, Andy Reynolds Smith, said at the time that a demerger would lead to “two stronger companies.”

Completion and receipt of the initial cash proceeds is expected in the first half of 2022, subject to approval by Smiths' shareholders and customary regulator approvals,” the statement said.

Leading industrial technology group

Smiths Group CEO Paul Keel said: "Delivering on our commitment to maximise value, the ICU transaction provides both a higher value for Smiths' shareholders, as well as future value creation through our 10% holding of the enlarged combined group and a potential $0.1bn additional contingent consideration.

"We are focused on concluding this superior transaction and on driving Smiths Group forward, delivering on our significant potential as a leading industrial technology group united by shared purpose, business characteristics and a common operating model."

Read more: Smiths seeks to sell 'odd child' medical division to US private equity firm, a newspaper report claims

Capital Com is an execution-only service provider. The material provided on this website is for information purposes only and should not be understood as an investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page then you do so entirely on your own risk.

Still looking for a broker you can trust?

Join the 400.000+ traders worldwide that chose to trade with

1. Create & verify your account

2. Make your first deposit

3. You’re all set. Start trading